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ABSTRACT
Introduction: Our aim in this clinical trial was to compare the safety and efficacy of high-
viscosity cement (HVC) with low-viscosity cement (LVC) for the treatment of osteoporotic 
vertebrae fractures in terms of pain, functional capacity and cement leakage in the 
percutaneous vertebroplasty procedure (PVP).
Methods: From March 2013 to February 2015, 76 patients with vertebrae compression 
fracture who were admitted into hospital and treated with PVP were reviewed. Pre- and 
postoperative clinical characteristics of each patient were obtained by using The Visual 
Analog Scale (VAS) score to evaluate back pain, Oswestry Disability Index (ODI) as a 
functional assessment. Cement leakage,injected cement volume and the complications 
assessed due to medical records.
Results: VAS and ODI scores improved (P<0.05) significantly in the two groups 
postoperatively on the other hand there was no significant change between two groups 
(P>0.05).Paravertebral cement leakage was significantly higher in the LVC group (P<0.05). 
Pulmonary cement embolism was also significantly higher in LVC group (P<0.05). 
Conclusion: HVC had lower complication rates with similar clinical results in the 
comparison with LVC.
Keywords: Vertebroplasty, cement leakage, bone cement, viscosity, pulmonary 
embolism, vertebral fracture, osteoporosis
Level of evidence: Retrospective clinical study, Level III
INTRODUCTION
The most common systemic disorder 
worldwide is osteoporosis and it 
is characterized by decreased bone 
mass quality, transformed bone micro 
architecture and increased fracture risk 
(3,13). An estimated 22 million women 
and 5.5 million men are afflicted with 
osteoporosis at the European Union. 
When the treatment cost of fractures 
related to osteoporosis is added to the cost, 
it has been reached to 37.0 billion euro and 
is assumed to increase by 25 % in 2025 (9). 
With the aging of the population, 
osteoporotic vertebral compression 
fractures (OVCFs) incidence has been 
increased and it is becoming a serious 
socio-economic problem. Despite generally 
believed hypothesis is good prognosis for 
most of these fractures; OVCF worsens 
the long term patient’s health (18).
During the last decade, with the 
increased popularity at the minimally 
invasive surgery and development of new 
approaches and methods, percutaneous 
vertebroplasty (PVP) which includes 
percutaneously cement injection into the 
fractured vertebral body is an accepted 
technique for the treatment of the patients 
with painful OVCFs (6,11). For this purpose, 
multiple types of injectable bone cements 
like PolyMethylMetAcrylate (PMMA), 
calcium phosphate and composite cements 
are currently being used in PVP. PMMA 
is the most widely used cement type due 
to its good handling properties, strength, 
long time experience, and low costs.
Severe complications like spinal cord 
compression, nerve damage, blood vessels 
thermal damage and pulmonary embolism 
could be caused by leakage of the cement 
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the spine. On the other hand, little amount of cement leakage 
could be without clinical manifestation (15). The detection of 
cement leakage on plain roentgenograms is ranging from 43 
% to 45 % on the other hand on the computed tomography 
(CT) scan rates are changing between 78 % and 91.9 %. Due 
to these rates, leakage of the cement is a severe problem that 
spine surgeons have attempted to find a solution (5,19). 
The risk for extravasation could be effectively decreased 
by using high viscosity cement (HVC) and thereby clinical 
safety could be improved. In an experimental study Baroud 
et al. demonstrated that cement leakage could be stopped 
completely with HVC (4). Also in a prospective comparative 
clinical study Georgy and Anselmetti confirmed that HVC is 
safe in application and may decrease cement leakage at PVP 
procedure compared with low viscosity cements(LVC) (7,14). 
HVC directly reaches an optimum injectable viscosity after 
mixing, without a waiting period of few minutes as in LVC’s, 
and before the cement solidification it conserves the injectable 
form for 8–10 minutes.
Also in a retrospective study it has been shown that using 
HVC may have a role in decreasing the risk of cement leakage 
in PVP procedure and may result in leakage rates comparable 
with that of balloon kyphoplasty (2).
Our aim in this clinical trial was to compare the safety and 
efficacy of high-viscosity cement vertebroplasty (HVCV) 
with low-viscosity cement vertebroplasty (LVCV) for the 




From March 2013 to February 2015, 76 patients with vertebrae 
compression fracture who were admitted into hospital and 
treated with PVP were reviewed. 12 patient excluded from 
the study due to the exclusion criteria’s and 1 patient from 
the  group HVC died because of a cancer 1 patient from the 
group LVC died in a traffic accident during the follow-up. In 
62 patients there were 22 in male and 40 in female.
Patients were included in the study if they (1) were aged above 
50 years, (2) had severe OVCFs vertebrae or lumbar fracture 
without symptom and signs of spinal cord damage or pedicle 
damage (part of the vertebral body collapsed to less than 
one-third of their original height), (3) had focal back pain 
without definite radicular signs and symptoms unresponsive 
to at least 8 weeks of appropriate conservative treatment, (4) 
had back pain related to the location of the OVCF on spinal 
radiographs, (5) Vertebrae compression fracture confirmed by 
international recognized imaging (X plain film, CT, MRI T2-
weightedshort tau inversion recovery sequences) and clinical 
examination, and (6) Osteoporosis diagnosed by bone mineral 
density (BMD), BMD was less than 2.5 SD suggested the 
possibility of osteoporosis.
Patients were excluded if they (1) had ordinary OVCFs 
(vertebral body collapsed to more than one-third of their 
original height), (2) had spinal cord compression or stenosis of 
the vertebral canal > 30 % of the local canal diameter, (3) Injury 
of neural function including spinal cord damage or cauda 
equina injury, (4) Unable to undergo related examinations,(5) 
had systemic or local spine infections, and (6) had severe 
comorbidity in the heart, liver, kidney, and lung intolerance 
to surgery. (7) Blood coagulation dysfunction with bleeding (8) 
Poor compliant patients or loss to follow up during follow-
ups. 
The study population consisted of 29 patients in the group 
HVC (mean age, 75.4 ± 9.3 years) and 33 patients in the 
group LVC (mean age, 75.8 ± 9.1 years). All procedures were 
per-formed by the same surgeon (MA).
All patients had low back pain and pain when turning over 
and were unable to stand up. Besides, pain released when 
patient was in supine position and worsened when bending 
over. Physical examination showed that there were obvious 
tenderness and percussion pain at thoracic vertebrae or 
lumbar fracture site. 
Magnetic resonance imaging (MRI), thin slice computerized 
tomography (CT), dual-energy X-ray absorptiometry 
(DEXA), and anteroposterior (A/P) and lateral radiographs 
were evaluated before CT and AP-LAT radiographs after the 
surgery to determine the appropriateness of the procedure 
and plan the treated levels.
Cement leakage, defined as the presence of any extravertebral 
cement, was assessed independent of the treating physician by 
2 investigators using a computed tomography (CT) scan made 
after PVP. Differences were re-examined until consensus was 
obtained.
All procedures were carried out with sterile equipment. 
Patients were placed in a prone position on operating table, 
and sedation was achieved with 1.5 cc intravenous midazolam. 
The entry point was confirmed by C-arm X-ray machine and 
marked local anesthesia with 2% prilocaine hydrochloride (8 
cc) was administered from the pedicle of fractured vertebra 
to subcutaneous tissue. An 11-gauge needle was inserted into 
the pedicle via fluoroscopy. Using anteroposterior and lateral 
imaging, the pedicle was passed through the body to reach the 
corpus vertebrae. A biopsy has been taken for identifying if 
the fracture is due to the osteoporosis or not. Then, cementing 
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was performed, and a lateral X-ray showed the distribution of 
the cement inside the corpus. The amount of cement added 
was determined via lateral imaging. After the procedure, the 
patients remained motionless in a prone position until the 
cement polymerized. The patients underwent a neurological 
examination at every stage of the procedure. All of the patients 
stayed in the hospital for 1 day, and none of them had to wear 
a cast after discharge.
Pre- and postoperative clinical characteristics of each patient 
were obtained by using The Visual Analog Scale (VAS) score 
to evaluate back pain, Oswestry Disability Index (ODI) as a 
functional assessment. Routine standing anteroposterior and 
lateral radiographs of the spine were made 6 weeks and 1 year 
after PVP and on indication, e.g., sudden new onset of back 
pain suspect for a new OVCF.
Statistical analysis
IBM SPSS statistic 22.0 was applied in statistical analysis. 
All data were showed by mean ± SD. Intergroup comparisons 
were made using the Student’s paired t-test or Man Whitney 
U test. Comparisons between before and after operation 
were made using the paired simple t-test and Wilcoxon 




There were no significant differences between group HVC 
and group LVC in the gender ratios, age, and vertebral bodies 
involved according to the statistical results (Table-1). 
The time of follow-ups in group HVC and group LVC were 
1.0 - 2.1year (mean 1.6 ± 0.5) and 1.1 - 2.0 year (1.5 ± 0.6) 
respectively. Sixty-two surgeries were carried on 137 vertebrae.
Surgery time
The average surgery time was 20,97±3,24minutes on average 
for LVC, and 10,07±1,21minutes for HVC, There was 
statistical difference between the two groups according to the 
mean surgery time/vertebrae (P:0.001; P<0.05).
Amount of cement
All surgeries were completed successfully. The injected 
volume of HVC and LVC were 3,52 ± 1,09 ml and 3,39 ± 
1,2 ml respectively. There was no statistical difference about 
injected volume of bone cement (p: 0,551).
VAS ODI
The two groups reported immediate postoperative pain relief, 
and none had subjective complaints of worsening pain at any 
time point of follow-up. Group HVC the mean VAS score 
before PV of 8.41 ± 1.16 improved significantly, to a mean 
of 1.31 ± 0.69 at the end point after the procedure (Mann 
Whitney U test, Wilcoxon Sign test, p<0.05). In Group LVC the 
mean VAS of 8.36 ± 0.99 pre-procedure dropped to 1.36 ± 
0.83 post-procedure respectively (P<0.05) 12 months follow-
up (Table-2).
Table-1. Table showing demographic data of patients 
included in this study
GROUP  HVC GROUP LVC P-value
Number of 
Participants 29 33
MEN/WOMEN 10/19 12/21 1.00
Vertebral Bodies (n) 61 66
Mean Age 72,46±8,03 74,84±5,84 10,191






Surgery Time 10,07±1,21 20,97±3,24 10,001*
Cement Volume 3,52±1,09 (3) 3,39±1,2 (3) 20,551
Table-2.  Comparison of VAS  between two groups
VAS 
GROUP LVC GROUP HVC
p1
Mean±SD Mean±SD 
PREOPERATIVE 8,36±0,99 8,41±1,16 0,878
POSTOPERATIVE 1,36±0,83 1,31±0,69 0,821
Preoerative- 
Postoperative p2 0,001* 0,001*
1Mann Whitney U test  2Wilcoxon Sign test *p<0.05
ODI scores also improved (P<0.05) significantly in the two 
groups, from a mean index of 43.88% ± 3.97 to 6.94% ± 
2.63% (Group HVC) and from 42.82% ± 6.2% to 6.71% ± 
2% (Group LVC). No differences in clinical outcome were 
noted between the two groups (p > 0.05) (Table-3).
Table-3. Comparison of ODI between two groups
ODI 
GROUP LVC GROUP HVC
p1
Mean±SD Mean±SD
PREOPERATIVE 42,82±6,2 43,88±3,97 0,444
POSTOPERATIVE 6,71±2 6,94±2,63 0,715
Preoerative-
Postoperative p2 0,001* 0,001*
1Student t test 2Paired Samples test *p<0.05
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Complication
No significant clinical complications or post-procedural 
clinical sequelae were encountered in both groups. 
Comparison of data showed a statistically highly significant 
difference (p: 0.023; p<0.05, Continutity Yates correction) 
of disc cement leakages between patients treated with group 
HVC and patients in Group LVC (Figure-1). 
In group HVC pulmonary embolism ratio was statistically 
higher than group LVC (P:0.037; P<0.05) (Table-4)
(Figure-2).
Figure-1. Arrow showing the pulmonary cement 
embolism in group LVC.
Figure-2. (A) Lateral plane x ray showing cement leakage 
to the disc and anterior wall of the vertebrae. (B) Anterior-
Posterior x ray arrow showing the cement leakage to the 
disc.
One elder patient with severe osteoporotic vertebrae body 
compression fracture (L-1) in group HVC had distal vertebrae 
fracture (L-2) postoperatively. Also one case of postoperative 
adjacent vertebrae fracture was found in group LVC. All new 
fractures were treated surgically. No statistical difference in 
new fracture rate was demonstrated between the groups. 
There was one case with a superficial wound infection that 
was treated with antibiotics in group LVC. 
Table-4. Comparison cement leakages and pulmonary 
embolism between two groups  
 GROUP LVC  GROUP HVC
p
n (%) n (%)
Disc cement leakage
- 17 (%60,7) 9 (%28,1)
0,023*
+ 11 (%39,3) 23 (%71,9)
Pulmonary embolism
- 19 (%67,9) 12 (%37,5)
0,037*
+ 9 (%32,1) 20 (%62,5)
Continuity (Yates) correction *p<0.05
DISCUSSION
Osteoporosis had become a kind of common disease with 
severe damage to elderly health (12). A female had a risk of 
osteoporotic fracture at 30 % ~ 40 % worldwide. The rate of 
osteoporosis was approximately 60 % for the aged over 60 
years old, 80 % of who were female.
Traditionally, osteoporosis-related compression fractures of 
the spine have been treated conservatively, with analgesics 
and long-term bed rest. However, it is now well accepted that 
PVP is the treatment of choice for patients with osteoporotic 
compression fractures. It results in lower morbidity and 
mortality than open surgery and avoids prolonged immobility. 
A review of the recent literature on spinal metastases treated 
with percutaneous transpedicular vertebroplasty revealed that 
complete or partial pain relief (1–3 days postoperatively) 
was achieved in 75–89% of patients (1,10,16-17). The results of 
our study were at least as successful in treating patients with 
pathological vertebral body collapse using PVP.
PVP was the one of clinical common operation treatment 
with severe complication of bone cement leakage. Some 
studies showed that LVC had a higher rate of cement leakage 
and para-vertebrae leakage than HVC (4,8). LVC was easy to 
leak and diffuse to vein to induce pulmonary embolism with 
disadvantage of short solidification time and inconvenient 
operation. Also in our study we found statistically higher 
cement leakage rates in LVC.
Three major factors may influence the cement flow into 
and out of the vertebral body: bone- and fracture-related 
parameters, injection methods, and properties of cement. 
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Although fracture morphology is impossible to control and 
the method of injection has been standardized, the properties 
of cement may be manipulated to ultimately decrease the rate 
of leakage of cement. In terms of properties of cement, an 
increased viscosity leads to a uniformly expanding cloud and 
a decreased spreading distance ideally, ignoring preformed 
paths by vessels or structural irregularities, thus reducing the 
risk of leakage (4,7,14).
In group HVC there was a shorter surgery time using HVC in 
our study can be attributed to earlier beginning of application 
of the cement immediately after mixing the components of 
cement in group HVC, on the other hand surgeon have to 
wait polymerization of LVC to end to prevent leakage of 
cement in the surrounding musculature at removal of a needle.
It is unclear whether spatial distribution of the cement 
influenced by its viscosity affects the outcome of PVP. The 
results of the present study showed a clinically relevant, 
significant, immediate, and durable reduction in mean back 
pain and function, which was comparable between both the 
groups. Thus there is no direct dependence between the 
quantity of cement applied and clinical outcome.
In fact our study had limitations. First, it was a retrospective 
study and the patients were not classified according to the 
fracture type. Secondly the small size of the study group was a 
limitation of our study. Also, the research assistants involved in 
the data collection of this study were not blinded to treatment 
type and may have introduced bias. Finally, length of follow-
up in this study is a limitation. 
This study showed that HVC had a lower rate of postoperative 
cement leakage because HVC was improved on basis of 
LVC, which could improve the liquid phase in the process of 
bone cement mixing and decrease the leakage rate and other 
complication rate to enhance the safety of PVP. A controlled 
prospective, high-powered, randomized multicenter studies 
also including the medium viscosity cement need to be 
designed to determine the differences in patient outcomes and 
to further elucidate optimal treatment strategies for VCF’s. 
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